Spots Global Cancer Trial Database for thiscart19a
Every month we try and update this database with for thiscart19a cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia | NCT05576181 | Allogeneic, CAR... | ThisCART19A Fludarabine Ora... Cyclophosphamid... VP-16 HSCT | 14 Years - 75 Years | Fundamenta Therapeutics, Ltd. | |
| Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma | NCT05776407 | Refractory or R... | ThisCART19A Fludarabine Cyclophosphamid... Etoposide | 18 Years - 65 Years | Chongqing University Cancer Hospital | |
| Evaluate the Safety and Effect of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/Lympholeukemia | NCT05340829 | AIDS Related Ly... | ThisCART19A | 18 Years - 65 Years | Zhejiang University | |
| Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy | NCT05640713 | Allogeneic, CAR... | ThisCART19A Fludarabine Pil... Cyclophosphamid... VP-16 Protocol | 18 Years - 75 Years | Henan Cancer Hospital | |
| Evaluate the Safety and Effect of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/Lympholeukemia | NCT05340829 | AIDS Related Ly... | ThisCART19A | 18 Years - 65 Years | Zhejiang University | |
| Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia | NCT05576181 | Allogeneic, CAR... | ThisCART19A Fludarabine Ora... Cyclophosphamid... VP-16 HSCT | 14 Years - 75 Years | Fundamenta Therapeutics, Ltd. | |
| Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B Cell Malignancies After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy | NCT05640713 | Allogeneic, CAR... | ThisCART19A Fludarabine Pil... Cyclophosphamid... VP-16 Protocol | 18 Years - 75 Years | Henan Cancer Hospital | |
| Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia | NCT05576181 | Allogeneic, CAR... | ThisCART19A Fludarabine Ora... Cyclophosphamid... VP-16 HSCT | 14 Years - 75 Years | Fundamenta Therapeutics, Ltd. | |
| Evaluate the Safety and Effect of ThisCART19A in Patients With AIDS Related B Cell Lymphoma/Lympholeukemia | NCT05340829 | AIDS Related Ly... | ThisCART19A | 18 Years - 65 Years | Zhejiang University | |
| Safety and Efficacy of ThisCART19A Bridging Hematopoietic Stem Cell Transplantation in Patients With Refractory or Relapsed B-cell Acute Lymphoblastic Leukemia | NCT05576181 | Allogeneic, CAR... | ThisCART19A Fludarabine Ora... Cyclophosphamid... VP-16 HSCT | 14 Years - 75 Years | Fundamenta Therapeutics, Ltd. | |
| Assessment of Safety and Efficacy of ThisCART19A in Adult Patients With B-NHL After Failure of Autologous Chimeric Antigen Receptor T- Cell(CAR-T) Therapy | NCT05349266 | Non-Hodgkin's L... | ThisCART19A | 18 Years - 75 Years | Zhejiang University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
